Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKSE: 874) is trading at HK$13.31, about ₹163 at today's HKD/INR rate, as of 30 Sep 2026, 4:08 AM ET, up 1.76% today. Indian residents can buy Guangzhou Baiyunshan Pharmaceutical Holdings from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$12.95
Today's high
HK$13.34
52 week low
HK$12.74
52 week high
HK$20.40
874 opened at HK$12.96, closed previously at HK$13.08, and has traded between HK$12.74 and HK$20.40 over the past 52 weeks.
About
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GBPHCL) is a comprehensive pharmaceutical enterprise focused on the research, development, production, and distribution of a wide array of medical products. These offerings span traditional Chinese patent medicines, Western pharmaceuticals, chemical raw materials and their intermediates, alongside natural and biological remedies, serving both the Chinese domestic market and international clientele. The company's operations are strategically divided into four primary segments: Great Southern TCM, Great Commerce, Great Health, and Others. Beyond its manufacturing activities, GBPHCL is actively involved in the import, export, wholesale, and retail of both Western and Chinese medicines, as well as medical equipment. The company also develops, manufactures, and sells various consumer goods including beverages, food products, health supplements, pre-packaged foods, dairy items, and diverse pharmaceutical forms such as tablets, capsules, lozenges, and injections, in addition to traditional items like tortoise herb jelly. Furthermore, GBPHCL makes strategic investments in the broader health industry, covering areas like medical services, health management, wellness initiatives, and elderly care. It also provides commercial and advertising solutions. As of December 31, 2021, the company maintained a substantial retail presence, managing 154 chain pharmacies operating under brands like Cai Zhi Lin, Jian Min, GPC Prescription Pharmacy, and Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd, supplemented by an additional 22 independent retail stores. Established in 1997, the company originally operated as Guangzhou Pharmaceutical Company Limited before adopting its current name, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, in August 2013. Its headquarters are situated in Guangzhou, China.
Key statistics
Avg. volume
1.08M
Market cap
HK$33.07B
P/E Ratio
12.48
Price-to-sales ratio
0.41
Enterprise value
CN¥31.63B
Free cash flow yield
-3.69%
Debt-to-equity ratio
0.50
Return on equity
7.89%
ROIC
4.81%
Beta
0.18
Dividend yield
3.80%
Last dividend
HK$0.79
Financial overview
Revenue
CN¥77.66B
Earnings per share
CN¥1.83
Free cash flow
-CN¥954.34M
Net profit margin
3.29%
Gross margin
15.48%
EBITDA
CN¥3.95B
Revenue growth
3.55%
Similar securities
This is not an investment recommendation
How to buy Guangzhou Baiyunshan Pharmaceutical Holdings from India
Indian residents can buy Guangzhou Baiyunshan Pharmaceutical Holdings shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Guangzhou Baiyunshan Pharmaceutical Holdings and place an order
Find Guangzhou Baiyunshan Pharmaceutical Holdings by name or by its ticker, 874, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Guangzhou Baiyunshan Pharmaceutical Holdings trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Guangzhou Baiyunshan Pharmaceutical Holdings position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Guangzhou Baiyunshan Pharmaceutical Holdings from India
Trading and taxes when buying Guangzhou Baiyunshan Pharmaceutical Holdings from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. Guangzhou Baiyunshan Pharmaceutical Holdings’ current yield is 3.80%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Guangzhou Baiyunshan Pharmaceutical Holdings stock?
Yes. Guangzhou Baiyunshan Pharmaceutical Holdings (874) has been listed on the Hong Kong Stock Exchange since 1997, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Guangzhou Baiyunshan Pharmaceutical Holdings share cost in rupees?
One Guangzhou Baiyunshan Pharmaceutical Holdings share is HK$13.31 — about ₹163 at an HKD/INR rate of 12.24 on 29 Sep 2026. Both the Guangzhou Baiyunshan Pharmaceutical Holdings price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Guangzhou Baiyunshan Pharmaceutical Holdings from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Guangzhou Baiyunshan Pharmaceutical Holdings?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Guangzhou Baiyunshan Pharmaceutical Holdings shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Guangzhou Baiyunshan Pharmaceutical Holdings price. Paasa issues a capital-gains statement for your return.
Does Guangzhou Baiyunshan Pharmaceutical Holdings pay a dividend, and how is it taxed in India?
Yes. Guangzhou Baiyunshan Pharmaceutical Holdings pays a dividend and the current yield is 3.80%; the last declared dividend was HK$0.79 per share, about ₹9.63. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade Guangzhou Baiyunshan Pharmaceutical Holdings from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Guangzhou Baiyunshan Pharmaceutical Holdings a Hong Kong SAR China company, and does that change how it is taxed?
Guangzhou Baiyunshan Pharmaceutical Holdings trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Guangzhou Baiyunshan Pharmaceutical Holdings trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Guangzhou Baiyunshan Pharmaceutical Holdings shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Guangzhou Baiyunshan Pharmaceutical Holdings holding, its cost and its closing value.
How do I sell Guangzhou Baiyunshan Pharmaceutical Holdings and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.